Chronos Archive seal

Review checklist: Benny Leonard (HR-BX008)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the stress echocardiogram as the test for exertional symptoms, hypertensive hypertrophy against hypertrophic cardiomyopathy, the sudden cardiac death risk discussion without Holter monitoring or a defibrillator, the calcium score and statin intensity, aspirin deferred, the single-pill start and titration, the missed potassium and creatinine check after the dose increase, the thiazide in summer heat and the change to amlodipine, and the return-to-work plan for refereeing.
provenance reviewnot_startedSources: the Scribner Encyclopedia of American Lives (Encyclopedia.com), EBSCO Research Starters, the International Jewish Sports Hall of Fame, Jews in Sports Online, the Stark Center at the University of Texas at Austin, and Bud Greenspan's 1983 New York Times eyewitness account as reprinted by the International Boxing Research Organization. The contemporary New York Times obituary could not be fetched. The cause of death is disputed (heart attack in most sources, cerebral hemorrhage in one) and is graded R; no earlier heart disease is documented.
safe messaging reviewnot_startedHis Jewish identity and the antisemitism of his era are recorded as documented history and with respect; the modern episode notes only that visits avoid the major holidays. His parents appear only in documented history claims; no relative has a role, statement, decision or health fact in the modern episode, and the family history is empty. His death in the ring is recorded on the timeline only; the modern episode makes no claim about its cause. PHQ-9 5 and 2, item 9 scored 0, so no safety assessment is required.

Judgment calls (dossier editorial resolutions)

  1. Sources. The contemporary New York Times obituary could not be fetched (the site blocks this tool), the International Boxing Hall of Fame page could not be reached, and the jewishsports.net biography returned not found. The record rests on the Scribner Encyclopedia of American Lives, EBSCO Research Starters, the International Jewish Sports Hall of Fame, Jews in Sports Online, the Stark Center at the University of Texas at Austin, and Bud Greenspan's 1983 New York Times eyewitness account, read in full in the International Boxing Research Organization reprint. The Greenspan piece is the only source for the details of the night of his death and for Leonard's own words about his retirement, his losses and his comeback; it is quoted as his recollection.
  2. Thin documented health history. No illness, injury, heart condition, blood pressure reading or physician's warning before his death is documented in any source read. In his own words he retired “without a scratch.” The past medical history and family history are therefore empty, and nothing is added. The modern episode is built around a common, defensible pattern that fits his documented life as a referee in his fifties: stage 2 hypertension with hypertensive heart disease and subclinical coronary atherosclerosis, found at a license examination, with a sudden cardiac death risk assessment and a return-to-work plan.
  3. Cause of death (CLM-0010, R, disputed). Most sources call it a heart attack (EBSCO, the Stark Center, Jews in Sports); the Scribner biography gives a cerebral hemorrhage; no autopsy finding was found. The cause is graded R with certainty “disputed,” kept off the problem list and shown on the timeline only. The modern diagnoses are synthetic choices, not a retrospective diagnosis of how he died. The roster's “cardiovascular disease” is not documented before his death and is not used as a historical claim.
  4. Date of death. April 18, 1947 is used (Scribner, the hall of fame, the roster); it was a Friday, the arena's fight night that Greenspan describes. EBSCO gives April 17, and Greenspan, writing 36 years later, gives April 19; both are recorded as conflicting alternatives.
  5. Era. The brief gives the era as “Mid-Late 20th Century”; the roster's master row gives “Early 20th Century” for Leonard, whose career ran from about 1911 to 1932. The record follows the roster.
  6. Retirement date and age. The hall of fame and EBSCO give January 1925 and Leonard himself said 1925; the Scribner biography gives 1924. The record uses January 1925. He was 28 at that retirement and 35 at the comeback in October 1931.
  7. Refereeing. The hall of fame says he returned to boxing as a referee in 1943; Scribner places his refereeing after the war. The record says he refereed in New York and taught at City College, without dating the start beyond the hall of fame's 1943.
  8. Name. The display name is “Benny Leonard”; the alias “Benjamin Leiner,” his birth name, appears in no other record. No other figure with a record in the dataset is named.
  9. Jewish identity and antisemitism (CLM-0001, CLM-0002, CLM-0004). His Orthodox Jewish upbringing, his refusal to fight on Jewish holidays, his standing as a symbol of the acceptance of Jews and Arthur Brisbane's words about antisemitism are recorded as documented history, in the sources' own terms. The modern episode notes only that he keeps the major holidays and asked that visits avoid them, and that he asked that his religious traditions be respected in hospital; it makes no other claim about his practice and uses no stereotype.
  10. Family. His parents appear only in documented history claims: their names and work, his keeping boxing from them, and his retirement at his mother's wish. A source's statement that his mother was ill in the 1920s is left out, so that no health fact about any relative is recorded. No relative has a role, statement, decision or health fact in the modern episode; the consultant records the family history as not known; the health care agent is unnamed.
  11. Index age and dates. The index visit on May 12, 2026 maps to May 12, 1946, when he was 50 and refereeing in New York after his wartime service. The synthetic date of birth is April 7, 1976 (shift 80 years). The visits on May 26, June 30, July 21, July 28, August 25 and October 27, 2026 map to the same days of 1946, all at age 50 and about six months or more before his death. His death is on the timeline only and is left out of the intake documents.
  12. Financial strain (CLM-0005, CLM-0006). His wealth at retirement, his loss in the 1929 crash and his comeback are documented, largely in his own words. The modern episode carries them as a social factor: worry about money and his license (PHQ-9 5, GAD-7 6 at intake, falling to 2 and 3), low-cost generic once-daily medicines, and a social needs screen without food or housing insecurity. No financial-insecurity diagnosis code is used.
  13. Distinct from other cardiac records. Other records already teach stable angina with coronary stenting and coronary disease with chest pain. This record's focus is different: hypertensive heart disease with left ventricular hypertrophy, exertional symptoms shown not to be ischemic, sudden cardiac death risk without a device or monitoring, a calcium score that drives the statin decision, thiazide-related volume depletion in a man who sweats heavily at work, and a return-to-work plan.
  14. Clinical judgment calls. (1) Treatment started at intake for stage 2 hypertension with hypertrophy on the ECG, with home monitoring to confirm and titrate, rather than waiting. (2) Single-pill losartan-hydrochlorothiazide as two first-line drugs, chosen for cost. (3) Exercise stress echocardiography rather than coronary CT angiography for exertional symptoms, to test ischemia, working capacity and the blood pressure response together. (4) Hypertensive hypertrophy judged from concentric, modest thickening without outflow obstruction; cardiac MRI held for non-regression. (5) No ambulatory ECG monitoring or defibrillator without palpitations, fainting or arrhythmia. (6) A noncontrast coronary calcium score added to the stress test to refine an uncertain statin decision (LDL 160 mg/dL with an intermediate estimated risk); a score of 186 favored a statin, and atorvastatin 40 mg was chosen with an LDL goal below 70 mg/dL. A reviewer may prefer coronary CT angiography, which would have answered both the symptom and the plaque questions in one test. (7) Aspirin deferred while blood pressure was uncontrolled, then declined by shared decision. (8) Return to work by analogy with the athlete eligibility statement: undercards until home readings were below 140/90, then full cards, with hydration, warning symptoms and a defibrillator at ringside. (9) After volume depletion on the thiazide, a change to losartan with amlodipine rather than restarting the thiazide. (10) Pneumococcal and zoster vaccines at 50; hepatitis B vaccine after the screening panel; FIT for colorectal screening by his choice.
  15. Synthetic clinical picture. Everything in the modern episode is synthetic: every result and score (laboratory tests, echocardiographic measures, PHQ-9, PHQ-2, GAD-7, AUDIT-C), the ECGs, the echocardiogram, the stress test, the calcium score, the examinations, the medicines, the volume depletion and the screening results. Height (165 cm) and weights are synthetic.
  16. Preventive visit. A periodic adult preventive visit at 50 (CPT 99396 with a problem-oriented visit, CPT 99213 with modifier 25, in plain text), which also served as the recheck a week after the sick visit: PCV20 and the first recombinant zoster dose, HIV, hepatitis C and hepatitis B screening (negative; not immune to hepatitis B, so vaccinated at the next two visits), FIT (negative), advance care planning; PSA and lung cancer screening not indicated.
  17. Sick visit. Orthostatic lightheadedness from volume depletion after refereeing a full card in a heat wave on losartan 100 mg with hydrochlorothiazide 25 mg (creatinine 1.44 mg/dL, potassium 3.3 mmol/L), chosen because it follows from his work and the regimen; the cardiologist had foreseen it. Oral rehydration, the tablet held for a week, recovery by the recheck, and a change to losartan with amlodipine. It is not a historical claim.
  18. Focused visits. The four chronic-care follow-ups (two weeks, with the consultation; seven weeks; fifteen weeks; twenty-four weeks) are documented as focused visits on the CMID hypertension, hyperlipidemia and ischemic heart disease monographs, the 2025 AHA/ACC blood pressure guideline, the 2026 ACC/AHA dyslipidemia guideline, the 2023 chronic coronary disease guideline, the 2021 chest pain guideline, the 2019 primary prevention guideline (aspirin), the 2015 athlete eligibility statement on hypertension, and the USPSTF depression and anxiety recommendations. One deviation is recorded instead of an invented result: the basic metabolic panel ordered two weeks after the dose increase at the seven-week visit was not drawn; the next check came at the sick visit three weeks after the increase, during volume depletion; the earlier check would probably not have prevented the heat-related episode, though low potassium might have been found sooner; the corrective action was a standing laboratory order with a reminder call after every medication change. The repeat echocardiogram is recorded as due, six to twelve months after the first, beyond the episode.
  19. Consultation. The cardiology referral and the consultation by Daniel Achebe-Lindqvist, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: no inducible ischemia, with the symptoms explained by the blood pressure response in a hypertrophied ventricle; hypertensive hypertrophy rather than hypertrophic cardiomyopathy; sudden cardiac death risk managed by blood pressure control without monitoring or a device; atorvastatin 40 mg after a calcium score of 186, with aspirin deferred; and a return to full refereeing once home readings were below 140/90, with losartan and amlodipine as the alternative if the thiazide caused trouble in the heat, which it did.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-26
Progress note 02 (C-CDA)
Aspirin decisionWhen risk changesNot started while blood pressure is uncontrolled; to be revisited once it is controlled
2026-08-25
Progress note 06 (C-CDA)
Basic metabolic panel (sodium, potassium, creatinine, eGFR)Two to four weeks after starting or changing an ARB or diuretic; then every six monthsThe panel ordered two weeks after the dose increase at the seven-week visit was not drawn: he was refereeing four nights that week, and no reminder call was made. The next check was at the sick visit three weeks after the increase, during volume depletion in a heat wave (creatinine 1.44 mg/dL, potassium 3.3 mmol/L), which recovered within a week. An earlier check would probably have been normal and would not have prevented the heat-related episode, but a fall in potassium on the higher thiazide dose could have been found sooner. Corrective action: a standing laboratory order with a reminder call for every check after a medication change

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-07-28
Progress note 05 (C-CDA)
PreventionColorectal cancer screeningOrderedDue from 45; he chose a yearly FIT; kit given today

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0010His sudden death is described in most sources as a heart attack; one reference work gives a cerebral hemorrhage. No autopsy finding was found in the sources read, and no earlier heart disease is documented.disputed

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-05-12Total cholesterol234 mg/dL (high)High
2026-05-12LDL cholesterol (calculated)160 mg/dL (high)High
2026-05-12Triglycerides150 mg/dL (high)High
2026-05-26Interventricular septal thickness in diastole (echocardiogram)13 mm (high)High
2026-05-26Left ventricular mass index (echocardiogram)118 g/m2 (high)High
2026-05-26Left atrial volume index (echocardiogram)36 mL/m² (high)High
2026-07-21Sodium133 mmol/L (low)Low
2026-07-21Potassium3.3 mmol/L (low)Low
2026-07-21Urea nitrogen32 mg/dL (high)High
2026-07-21Creatinine1.44 mg/dL (high)High
2026-07-21eGFR57 mL/min/1.73 m² (low)Low
2026-07-21Glucose104 mg/dL (high)High